Nothing Special   »   [go: up one dir, main page]

Ganji et al., 2015 - Google Patents

Development of mouse preantral follicle after in vitro culture in a medium containing melatonin

Ganji et al., 2015

View HTML
Document ID
12110813857101270844
Author
Ganji R
Nabiuni M
Faraji R
Publication year
Publication venue
Cell Journal (Yakhteh)

External Links

Snippet

Objective Improvements in cancer treatment have allowed more young women to survive. However, many cancer patients suffer from ovarian failure. Cryopreservation is one of the solutions for fertility restoration in these patients. The cryopreservation of isolated follicles is …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids

Similar Documents

Publication Publication Date Title
Ganji et al. Development of mouse preantral follicle after in vitro culture in a medium containing melatonin
Abedelahi et al. Sodium selenite improves the in vitro follicular development by reducing the reactive oxygen species level and increasing the total antioxidant capacity and glutathione peroxide activity
Nottola et al. Ultrastructure of human mature oocytes after slow cooling cryopreservation using different sucrose concentrations
Jang et al. Ameliorative effects of melatonin against hydrogen peroxide‐induced oxidative stress on boar sperm characteristics and subsequent in vitro embryo development
Abir et al. Morphological study of fully and partially isolated early human follicles
Klocke et al. Slow-freezing versus vitrification for human ovarian tissue cryopreservation
Nikmard et al. Effects of melatonin on oocyte maturation in PCOS mouse model
Shahedi et al. The effect of vitrification on ultrastructure of human in vitro matured germinal vesicle oocytes
Liang et al. Protective effect of antioxidants on the pre-maturation aging of mouse oocytes
Bianchi et al. Fine morphological assessment of quality of human mature oocytes after slow freezing or vitrification with a closed device: a comparative analysis
Hatami et al. The impact of alpha lipoic acid on developmental competence of mouse vitrified pre-antral follicles in comparison to those isolated from vitrified ovaries
Kedem et al. Alginate scaffold for organ culture of cryopreserved-thawed human ovarian cortical follicles
Hatami et al. Comparison of oxidative status of mouse pre‐antral follicles derived from vitrified whole ovarian tissue and vitrified pre‐antral follicles in the presence of alpha lipoic acid
Farzollahi et al. Supplementation of culture media with vitamin E improves mouse antral follicle maturation and embryo development from vitrified ovarian tissue
Li et al. Ovarian tissue cryopreservation for patients with premature ovary insufficiency caused by cancer treatment: optimal protocol
Tian et al. Microencapsulation and nanowarming enables vitrification cryopreservation of mouse preantral follicles
Tian et al. Effects of vitrification cryopreservation on follicular morphology and stress relaxation behaviors of human ovarian tissues: sucrose versus trehalose as the non-permeable protective agent
Shahedi et al. Ultrastructure of in vitro matured human oocytes
Souza-Fabjan et al. In vitro production of small ruminant embryos: Latest improvements and further research
Criado et al. Human oocyte ultravitrification with a low concentration of cryoprotectants by ultrafast cooling: a new protocol
Hajarian et al. Replacement of serum with sericin in in vitro maturation and culture media: Effects on embryonic developmental competence of Sanjabi sheep embryo during breeding season
Khosravi et al. In vitro development of human primordial follicles to preantral stage after vitrification
Lopes et al. Vitrification of caprine secondary and early antral follicles as a perspective to preserve fertility function
Abedelahi et al. Fertility preservation among the cancer patients by ovarian tissue cryopreservation, transplantation, and follicular development
Harada et al. Where are oncofertility and fertility preservation treatments heading in 2016?